Capromorelin - Revision history

Prab: CSV import

2025-02-15T11:12:21Z

CSV import

← Older revision		Revision as of 11:12, 15 February 2025
Line 1:		Line 1:
	~~'''~~Capromorelin''' is a synthetic molecule that functions as a [[Ghrelin receptor\|ghrelin receptor]] agonist. It is primarily known for its role in stimulating [[Appetite\|appetite]] and increasing [[Growth hormone\|growth hormone]] (GH) secretion. Due to its mechanism of action, capromorelin has been explored for various clinical applications, including the treatment of [[Appetite Disorders\|appetite disorders]] and [[Growth Hormone Deficiency\|growth hormone deficiencies]] in both humans and animals.		== Capromorelin ==

	~~==Mechanism of Action==~~		[[File:Capromorelin_skeletal.svg\|thumb\|right\|Chemical structure of Capromorelin]]
	~~Capromorelin mimics the action of~~ [[~~Ghrelin]], a hormone known as the "hunger hormone," which is produced in the stomach and plays a key role in regulating appetite and the distribution and rate of use of energy~~. ~~By activating the ghrelin receptor, capromorelin increases the secretion~~ of ~~growth hormone from the [[Pituitary gland\|pituitary gland~~]], which can lead to increased appetite, weight gain, and muscle growth. This mechanism makes it a potential therapeutic agent for conditions characterized by inadequate growth or insufficient appetite.

	~~==Clinical Applications==~~		'''Capromorelin''' is a [[ghrelin receptor]] agonist that is primarily used as an appetite stimulant. It is a synthetic compound that mimics the action of the natural hormone [[ghrelin]], which is known to stimulate hunger and increase food intake. Capromorelin has been studied for its potential use in treating conditions associated with loss of appetite and weight loss, such as in elderly patients or those with chronic illnesses.
	~~===In Veterinary Medicine===~~
	Capromorelin ~~has found significant applications in veterinary medicine, particularly for dogs and cats~~. It is ~~approved for use in~~ the ~~United States under~~ the ~~trade name Entyce, for the treatment of~~ [[~~Canine Appetite\|inappetence~~]] ~~in dogs. The drug acts by stimulating appetite~~, ~~helping animals that may be suffering from conditions that reduce their desire~~ to ~~eat, thereby improving their overall health~~ and ~~quality~~ of ~~life~~.

	==~~=In Human Medicine=~~==		== Mechanism of Action ==
	Research into the use of capromorelin in human medicine is ongoing. Its potential to stimulate appetite and growth hormone secretion makes it a candidate for treating conditions such as cachexia (wasting syndrome), anorexia, and growth hormone deficiency. However, its use in humans is still under investigation, and more studies are needed to fully understand its efficacy and safety profile for these conditions.

	~~==Safety and Side Effects==~~		Capromorelin works by binding to the [[growth hormone secretagogue receptor]] (GHSR), which is the receptor for ghrelin. This binding stimulates the release of [[growth hormone]] from the [[pituitary gland]], which in turn can lead to increased appetite and food intake. The activation of GHSR by capromorelin also has effects on [[metabolism]] and [[energy homeostasis]].
	~~The safety profile of capromorelin has been evaluated in clinical trials~~, ~~primarily in~~ the ~~context~~ of ~~veterinary medicine. Common side effects~~ in ~~animals include gastrointestinal symptoms such as diarrhea~~ and ~~vomiting, as well as an increase in blood glucose levels~~. ~~In humans, the safety and side effect profile~~ of capromorelin ~~is still being determined through clinical trials~~.

	==~~Future Directions~~==		== Clinical Uses ==
	The ongoing research into capromorelin and its effects on appetite and growth hormone secretion may lead to new therapeutic applications, both in human and veterinary medicine. Its role in treating a variety of conditions related to growth hormone deficiency and appetite disorders holds promise, but further research is necessary to fully unlock its potential.

	[[~~Category:Pharmacology~~]]		Capromorelin has been investigated for its use in various clinical settings, particularly for its ability to stimulate appetite in patients who suffer from [[cachexia]] or other conditions that lead to significant weight loss. It has shown promise in improving appetite and increasing body weight in clinical trials.
	[[Category:~~Endocrinology~~]]
	[[Category:~~Veterinary Medicine~~]]		== Pharmacokinetics ==
	~~{{medicine-stub}}~~
	~~{{No image}}~~		The pharmacokinetic profile of capromorelin involves its absorption, distribution, metabolism, and excretion. After oral administration, capromorelin is absorbed into the bloodstream and distributed throughout the body. It is metabolized primarily in the [[liver]] and excreted through the [[urinary system]].

			== Side Effects ==

			Common side effects of capromorelin may include [[nausea]], [[vomiting]], and [[diarrhea]]. Some patients may also experience [[headache]] or [[dizziness]]. As with any medication, it is important to monitor for adverse effects and adjust the dosage as necessary.

			== Research and Development ==

			Research on capromorelin continues to explore its potential benefits and applications. Studies are ongoing to determine its efficacy and safety in different patient populations and to better understand its long-term effects.

			== Related Pages ==

			* [[Ghrelin]]
			* [[Growth hormone]]
			* [[Appetite stimulant]]
			* [[Cachexia]]

			[[Category:Appetite stimulants]]
			[[Category:Growth hormone secretagogues]]

Prab: CSV import

2025-02-10T07:41:11Z

CSV import

← Older revision		Revision as of 07:41, 10 February 2025
Line 21:		Line 21:
	[[Category:Veterinary Medicine]]		[[Category:Veterinary Medicine]]
	{{medicine-stub}}		{{medicine-stub}}
			{{No image}}

Prab: CSV import

2024-03-22T09:44:33Z

CSV import

New page

'''Capromorelin''' is a synthetic molecule that functions as a [[Ghrelin receptor|ghrelin receptor]] agonist. It is primarily known for its role in stimulating [[Appetite|appetite]] and increasing [[Growth hormone|growth hormone]] (GH) secretion. Due to its mechanism of action, capromorelin has been explored for various clinical applications, including the treatment of [[Appetite Disorders|appetite disorders]] and [[Growth Hormone Deficiency|growth hormone deficiencies]] in both humans and animals.

==Mechanism of Action==
Capromorelin mimics the action of [[Ghrelin]], a hormone known as the "hunger hormone," which is produced in the stomach and plays a key role in regulating appetite and the distribution and rate of use of energy. By activating the ghrelin receptor, capromorelin increases the secretion of growth hormone from the [[Pituitary gland|pituitary gland]], which can lead to increased appetite, weight gain, and muscle growth. This mechanism makes it a potential therapeutic agent for conditions characterized by inadequate growth or insufficient appetite.

==Clinical Applications==
===In Veterinary Medicine===
Capromorelin has found significant applications in veterinary medicine, particularly for dogs and cats. It is approved for use in the United States under the trade name Entyce, for the treatment of [[Canine Appetite|inappetence]] in dogs. The drug acts by stimulating appetite, helping animals that may be suffering from conditions that reduce their desire to eat, thereby improving their overall health and quality of life.

===In Human Medicine===
Research into the use of capromorelin in human medicine is ongoing. Its potential to stimulate appetite and growth hormone secretion makes it a candidate for treating conditions such as cachexia (wasting syndrome), anorexia, and growth hormone deficiency. However, its use in humans is still under investigation, and more studies are needed to fully understand its efficacy and safety profile for these conditions.

==Safety and Side Effects==
The safety profile of capromorelin has been evaluated in clinical trials, primarily in the context of veterinary medicine. Common side effects in animals include gastrointestinal symptoms such as diarrhea and vomiting, as well as an increase in blood glucose levels. In humans, the safety and side effect profile of capromorelin is still being determined through clinical trials.

==Future Directions==
The ongoing research into capromorelin and its effects on appetite and growth hormone secretion may lead to new therapeutic applications, both in human and veterinary medicine. Its role in treating a variety of conditions related to growth hormone deficiency and appetite disorders holds promise, but further research is necessary to fully unlock its potential.

[[Category:Pharmacology]]
[[Category:Endocrinology]]
[[Category:Veterinary Medicine]]
{{medicine-stub}}